PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.93%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-34.20%
Negative gross profit growth while OGI.TO is at 152.57%. Joel Greenblatt would examine cost competitiveness or demand decline.
61.81%
EBIT growth similar to OGI.TO's 59.53%. Walter Schloss might infer both firms share similar operational efficiencies.
61.81%
Operating income growth similar to OGI.TO's 59.53%. Walter Schloss would assume both share comparable operational structures.
53.38%
Net income growth comparable to OGI.TO's 52.26%. Walter Schloss might see both following similar market or cost trajectories.
55.11%
EPS growth similar to OGI.TO's 53.66%. Walter Schloss would assume both have parallel share structures and profit trends.
55.11%
Similar diluted EPS growth to OGI.TO's 53.66%. Walter Schloss might see standard sector or cyclical influences on both firms.
5.26%
Share change of 5.26% while OGI.TO is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
5.26%
Diluted share change of 5.26% while OGI.TO is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
-136.34%
Negative OCF growth while OGI.TO is at 148.16%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-164.10%
Negative FCF growth while OGI.TO is at 126.45%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
No Data
No Data available this quarter, please select a different quarter.
373.08%
5Y revenue/share CAGR above 1.5x OGI.TO's 15.37%. David Dodd would look for consistent product or market expansions fueling outperformance.
-43.99%
Negative 3Y CAGR while OGI.TO stands at 17.35%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-41900.71%
Negative 10Y OCF/share CAGR while OGI.TO stands at 200.75%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
60.67%
5Y OCF/share CAGR at 50-75% of OGI.TO's 120.43%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
89.54%
3Y OCF/share CAGR under 50% of OGI.TO's 1527.02%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
-3781.62%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-193.75%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-402.19%
Negative 3Y CAGR while OGI.TO is 71.46%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
5906.98%
10Y equity/share CAGR above 1.5x OGI.TO's 494.58%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
-16.70%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-14.43%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-4.81%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
15.72%
Inventory growth well above OGI.TO's 0.35%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
2.21%
Asset growth above 1.5x OGI.TO's 0.19%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-2.95%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-4.65%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-56.11%
Our R&D shrinks while OGI.TO invests at 11.48%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-13.48%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.